Clinical Trial Update: Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

An update on a Phase 1 study of liposome-encapsulated docetaxel (LE-DT) in patients with solid tumors, with the trial status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Liposome Encapsulated Docetaxel (LE-DT) (docetaxel liposome)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED